DENGVAXIA LEAFLET - DENGUE
Home / dengue / 2018

Dengvaxia - Dengue Vaccine



Editor'S Choice
Thrombotic thrombocytopenic purpura: causes, symptoms and treatment
Thrombotic thrombocytopenic purpura: causes, symptoms and treatment
Dengvaxia is indicated for dengue prevention, indicated for children from 9 years of age and adults up to 45 years old, who live in epidemic areas. This vaccine works to prevent dengue caused by serotypes 1, 2, 3 and 4 of the dengue virus because it stimulates the body's natural defenses, leading to the production of antibodies against the dengue virus